Sanger sequencing analysis data using cfRNA from plasma samples in 6 cases, 10 samples, all from sarcoma.

We examined the levels of cfRNA in the blood of patients with malignant bone and soft tissue tumours harbouring specific fusion genes, to explore the relationship between fusion gene expression in the blood and therapeutic response and disease status, and to validate the clinical utility of liquid biopsy.

• Type: Case Set
• Archiver: Japanese Genotype-phenotype Archive (JGA)